Immunocore Holdings Analyst Price Targets

Wall Street analyst price targets and consensus rating for Immunocore Holdings (IMCR).

Price Target Range — 12 Quarters

Analyst Consensus — 14 Analysts

10Buy

4Hold

Consensus RatingBuy# Analysts14Avg. Consensus PT$62Upside to Avg. PT+104.2%

Rating Trend — Last 9 Months

Recent Analyst Actions

Ver todas las valoraciones →

Date	Firm	Analyst	Action	Rating Change	Price Target
Oct 26, 2026	HC Wainwright & Co.	Patrick R. Trucchio	Maintained	Buy	$100
Aug 21, 2026	JP Morgan	Jessica Fye	Reinstates	Overweight	$50
Aug 3, 2026	Mizuho	Graig Suvannavejh	PT Raise	Neutral	$34→$35
Apr 20, 2026	HC Wainwright & Co.	Patrick R. Trucchio	Maintained	Buy	$100
Apr 14, 2026	HC Wainwright & Co.	Patrick R. Trucchio	Maintained	Buy	$100
Mar 16, 2026	Jefferies	Clara Dong	Downgrade	Buy→Hold	$48→$33
Feb 26, 2026	Needham	Gil Blum	PT Raise	Buy	$71→$75
Feb 4, 2026	HC Wainwright & Co.	Patrick R. Trucchio	Maintained	Buy	$100
Jan 7, 2026	UBS	Michael Yee	Assumes	Sell→Buy	$24→$55
Nov 10, 2025	Morgan Stanley	Andrew Galler	PT Raise	Equal-Weight	$34→$36
Oct 31, 2025	Wells Fargo	Eva Fortea Verdejo	Initiate	Overweight	$60
Oct 22, 2025	HC Wainwright & Co.	Patrick R. Trucchio	Maintained	Buy	$100
Sep 18, 2025	Guggenheim	Paul Jeng	Assumes	Neutral	—
Jun 2, 2025	HC Wainwright & Co.	Patrick Trucchio	Maintained	Buy	$100
May 8, 2025	Oppenheimer	Jeff Jones	PT Raise	Outperform	$85→$86
May 7, 2025	Barclays	Peter Lawson	PT Cut	Overweight	$66→$52
Apr 14, 2025	JP Morgan	Jessica Fye	PT Cut	Overweight	$54→$50
Apr 10, 2025	Needham	Gil Blum	Maintained	Buy	$71
Apr 7, 2025	Mizuho	Graig Suvannavejh	PT Cut	Neutral	$38→$33
Mar 12, 2025	HC Wainwright & Co.	Patrick Trucchio	Maintained	Buy	$100

Analyst Ratings News

PRO
HC Wainwright & Co. Reiterates Buy on Immunocore Holdings, Maintains $100 Price Target

HC Wainwright & Co. analyst Patrick R. Trucchio reiterates Immunocore Holdings (NASDAQ:IMCR) with a Buy and maintains $100 price target.

Benzinga Newsdesk

PRO
JP Morgan Reinstates Overweight on Immunocore Holdings, Announces $50 Price Target

JP Morgan analyst Jessica Fye reinstates Immunocore Holdings (NASDAQ:IMCR) with a Overweight and announces $50 price target.

Benzinga Newsdesk

PRO
Mizuho Maintains Neutral on Immunocore Holdings, Raises Price Target to $35

Mizuho analyst Graig Suvannavejh maintains Immunocore Holdings (NASDAQ:IMCR) with a Neutral and raises the price target from $34 to $35.

Benzinga Newsdesk

PRO
HC Wainwright & Co. Reiterates Buy on Immunocore Holdings, Maintains $100 Price Target

HC Wainwright & Co. analyst Patrick R. Trucchio reiterates Immunocore Holdings (NASDAQ:IMCR) with a Buy and maintains $100 price target.

Benzinga Newsdesk

PRO
HC Wainwright & Co. Reiterates Buy on Immunocore Holdings, Maintains $100 Price Target

HC Wainwright & Co. analyst Patrick R. Trucchio reiterates Immunocore Holdings (NASDAQ:IMCR) with a Buy and maintains $100 price target.

Benzinga Newsdesk

PRO
Jefferies Downgrades Immunocore Holdings to Hold, Lowers Price Target to $33

Jefferies analyst Clara Dong downgrades Immunocore Holdings (NASDAQ:IMCR) from Buy to Hold and lowers the price target from $48 to $33.

Benzinga Newsdesk

Immunocore Holdings PLC

Noticias

SOCIO/CONTRIBUIDOR

BENZINGA GLOBAL

Immunocore Holdings Analyst Price Targets

Recent Analyst Actions

Analyst Ratings News

PRO
HC Wainwright & Co. Reiterates Buy on Immunocore Holdings, Maintains $100 Price Target

PRO
JP Morgan Reinstates Overweight on Immunocore Holdings, Announces $50 Price Target

PRO
Mizuho Maintains Neutral on Immunocore Holdings, Raises Price Target to $35

PRO
HC Wainwright & Co. Reiterates Buy on Immunocore Holdings, Maintains $100 Price Target

PRO
HC Wainwright & Co. Reiterates Buy on Immunocore Holdings, Maintains $100 Price Target

PRO
Jefferies Downgrades Immunocore Holdings to Hold, Lowers Price Target to $33

People Also Watch

People Also Watch

Immunocore Holdings PLC

Noticias

SOCIO/CONTRIBUIDOR

BENZINGA GLOBAL

Immunocore Holdings Analyst Price Targets

Recent Analyst Actions

Analyst Ratings News

PROHC Wainwright & Co. Reiterates Buy on Immunocore Holdings, Maintains $100 Price Target

PROJP Morgan Reinstates Overweight on Immunocore Holdings, Announces $50 Price Target

PROMizuho Maintains Neutral on Immunocore Holdings, Raises Price Target to $35

PROHC Wainwright & Co. Reiterates Buy on Immunocore Holdings, Maintains $100 Price Target

PROHC Wainwright & Co. Reiterates Buy on Immunocore Holdings, Maintains $100 Price Target

PROJefferies Downgrades Immunocore Holdings to Hold, Lowers Price Target to $33

People Also Watch

People Also Watch

PRO
HC Wainwright & Co. Reiterates Buy on Immunocore Holdings, Maintains $100 Price Target

PRO
JP Morgan Reinstates Overweight on Immunocore Holdings, Announces $50 Price Target

PRO
Mizuho Maintains Neutral on Immunocore Holdings, Raises Price Target to $35

PRO
HC Wainwright & Co. Reiterates Buy on Immunocore Holdings, Maintains $100 Price Target

PRO
HC Wainwright & Co. Reiterates Buy on Immunocore Holdings, Maintains $100 Price Target

PRO
Jefferies Downgrades Immunocore Holdings to Hold, Lowers Price Target to $33